Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease [0.03%]
在炎症性肠病管理中靶向免疫调节剂的剂量递增评估
Rahel Ehrenberg,Jenny Griffith,Cindy Theigs et al.
Rahel Ehrenberg et al.
Background: The need for individualized treatment regimens is becoming more important in the management of patients with inflammatory bowel disease (IBD). Gastroenterologists may dose adjust either by increasing the dose ...
Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States [0.03%]
美国产后抑郁症患者使用brexanolone治疗的 cost-effectiveness研究与选择性血清素摄取抑制剂相比
Adi Eldar-Lissai,Joshua T Cohen,Samantha Meltzer-Brody et al.
Adi Eldar-Lissai et al.
Background: Brexanolone injection (BRX) was approved by the FDA in 2019 for the treatment of adult patients with postpartum depression (PPD), but its cost-effectiveness has not yet been evaluated. ...
AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits? [0.03%]
AMS合作论坛：数字疗法是什么以及它们在药品和医疗福利中扮演什么角色？
Digital therapeutics (DTx)-software that delivers a clinical mechanism of action, either alone or in combination with other standard-of-care treatments to improve outcomes-is an emerging class of therapeutic interventions that poses many qu...
Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits [0.03%]
自费参保者体内提取与体外 pharmacy 利益的医疗费用和医疗保健利用情况
Julia J Smith,Yang Qiu,Steve V Lam et al.
Julia J Smith et al.
Background: Pharmacy benefit can be purchased as part of an integrated medical and pharmacy health package-a carve-in model-or purchased separately and administered by an external pharmacy benefit manager-a carve-out mode...
Jody Gembarski,Joseph Couto,Marcus Wilson;Contributors from the Joint Research Committee of AMCP and the AMCP Foundation
Jody Gembarski
Research agendas play valuable roles in clearly identifying high-priority topics that reflect potential to improve health care quality. The purpose of this report is to present work completed by the Academy of Managed Care Pharmacy (AMCP) a...
Editor's Note [0.03%]
编者按
Laura E Happe
Laura E Happe
Importance of Patient-Centered Outcomes When Evaluating Treatments for Secondary Progressive Multiple Sclerosis [0.03%]
评估继发进展型多发性硬化症治疗时患者结局的重要性
Taddei-Allen Patty
Taddei-Allen Patty
No funding supported the writing of this commentary. The author has nothing to disclose.
Dominique Medaglio,Justin Glasgow,Zugui Zhang et al.
Dominique Medaglio et al.
Background: Timely initiation of medication therapy after a cardiovascular event is vital to achieve optimal patient outcomes, yet there is a lack of insight on the frequency and predictors of discharge medications that a...
Implementing California Senate Bill 493 in an Outpatient Pharmacy Within an Integrated Health System: Evaluation of the Operational and Clinical Effect of Pharmacist-Ordered Laboratory Tests [0.03%]
《门诊药房药师开具检验订单的操作和临床影响评价——基于加州SB493法案在集成化医疗体系中的实行》
Hector M Delgado,Nicole P Kleinman,Abir F Makarem et al.
Hector M Delgado et al.
Background: Under California Senate Bill 493, pharmacists can order patient laboratory tests (labs). Currently, it is unknown if this service affects patient outcomes or pharmacy operations. Does lab ordering by pharmacis...
Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission [0.03%]
出院前床边发药评估：对30天再入院率的影响
Jodi B Segal,Ariella Apfel,Daniel J Brotman et al.
Jodi B Segal et al.
Background: This study is an evaluation of a discharge intervention that occurred in multiple hospitals across Maryland. In this program, patients received medications at their bedside before discharge with the goal of re...